Paradigm Biopharmaceuticals blues with Morgans
SYDNEY: Analyst price targets of where a stock will be in a year’s ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
FEATURED
Crown Melbourne ups entertainment appeal with The Palms redevelopment
The Star shares fly 26p.c. but investors aren’t buying for growth
Endeavour Group to close Prownie bottling facility near Gawler
Tabcorp executive shambles now headed to federal court
Online gambler yields to public frustration, drops TV ads for round one